Biofrontera Inc. to Participate in Benchmark’s 11th Annual Discovery One-on-One Investor Conference

Rhea-AI Summary

Biofrontera (Nasdaq: BFRI) announced its participation in Benchmark’s 11th Annual Discovery One-on-One Investor Conference on December 1, 2022, in New York, NY. CEO Erica Monaco and Executive Chairman Hermann Lübbert will engage with registered investors through one-on-one meetings and small-group sessions. The company specializes in dermatological products, focusing on treatments for actinic keratoses and impetigo.

For more details, please visit Biofrontera's website.

WOBURN, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) -- Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the Company will be participating in Benchmark’s 11th Annual Discovery One-on-One Investor Conference being held on December 1, 2022 in New York, NY.

Erica Monaco, Chief Executive Officer, and Hermann Lübbert, Executive Chairman of Biofrontera Inc. will be meeting with registered investors in one-on-one meetings and small-group sessions.

About Biofrontera Inc.

Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on PDT and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit https://www.biofrontera-us.com.

Contacts

Biofrontera Inc.
Anke zur Mühlen
+1 781 486 1539
us-ir@biofrontera.com

LHA Investor Relations
Tirth T. Patel
+1 212 201 6614
tpatel@lhai.com

# # #

FAQ

What is Biofrontera's participation in the December 2022 investor conference?

Biofrontera will participate in Benchmark’s 11th Annual Discovery One-on-One Investor Conference on December 1, 2022, in New York, where executives will hold meetings with investors.

Who from Biofrontera will attend the December investor conference?

CEO Erica Monaco and Executive Chairman Hermann Lübbert will attend the conference.

What is Biofrontera's focus in dermatological treatments?

Biofrontera focuses on products for treating actinic keratoses and impetigo, a bacterial skin infection.

Where can I find more information about Biofrontera?

For more information, visit Biofrontera's official website at https://www.biofrontera-us.com.

What stock symbols represent Biofrontera?

Biofrontera is represented by the stock symbols BFRI and BFRIW.